Phase 3 PARADIGM: HLP003 (Psilocibin-d10) for Adjunctive MDD Use | HCPLive

Two 12-week phase 3 trials and a 43-week extension will test 8 mg and 16 mg HLP003 added to antidepressants, with APPROACH enrollment now.